Sign in
4

Changes in Ownership

Spyre Therapeutics, Inc. Filed Acc 0000950170-24-048457

Director acquired 3,639,680 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Fairmount Funds Management LLC · Director

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2024-04-25 Exercise or conversion : show line 1 in the form +3,639,680 4,018,101 I

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-04-25 Exercise or conversion : show line 2 in the form Series A Preferred Stock −90,992 346,045 I
Loading xslF345X05/ownership.xml…